“The morning-after pill (MAP) lacks testing for safety to women...The drug owner encourages multiple sex partners (putting women at risk of sexually transmitted diseases, or STDs), and endorses frequent use of the drug, though it has not conducted studies on multiple use.”
From Wendy Wright
<
